Michael F. Price’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-3,583,668
| Closed | -$3.08M | – | 121 |
|
|
2019
Q4 | $3.08M | Hold |
3,583,668
| – | – | 0.43% | 52 |
|
|
2019
Q3 | $2.01M | Hold |
3,583,668
| – | – | 0.28% | 65 |
|
|
2019
Q2 | $1.86M | Hold |
3,583,668
| – | – | 0.24% | 72 |
|
|
2019
Q1 | $1.61M | Hold |
3,583,668
| – | – | 0.2% | 75 |
|
|
2018
Q4 | $1.72M | Hold |
3,583,668
| – | – | 0.23% | 71 |
|
|
2018
Q3 | $1.9M | Hold |
3,583,668
| – | – | 0.24% | 72 |
|
|
2018
Q2 | $1.79M | Hold |
3,583,668
| – | – | 0.21% | 74 |
|
|
2018
Q1 | $1.51M | Hold |
3,583,668
| – | – | 0.18% | 79 |
|
|
2017
Q4 | $1.36M | Hold |
3,583,668
| – | – | 0.17% | 82 |
|
|
2017
Q3 | $1.29M | Hold |
3,583,668
| – | – | 0.18% | 76 |
|
|
2017
Q2 | $1.36M | Hold |
3,583,668
| – | – | 0.18% | 77 |
|
|
2017
Q1 | $1.61M | Hold |
3,583,668
| – | – | 0.2% | 76 |
|
|
2016
Q4 | $1.36M | Hold |
3,583,668
| – | – | 0.17% | 85 |
|
|
2016
Q3 | $968K | Hold |
3,583,668
| – | – | 0.13% | 85 |
|
|
2016
Q2 | $861K | Hold |
3,583,668
| – | – | 0.11% | 91 |
|
|
2016
Q1 | $409K | Buy |
3,583,668
+1,886,675
| +111% | +$205K | 0.06% | 94 |
|
|
2015
Q4 | $191K | Buy |
1,696,993
+373,950
| +28% | +$52.8K | 0.02% | 115 |
|
|
2015
Q3 | $252K | Buy |
1,323,043
+48,043
| +4% | +$16.3K | 0.04% | 102 |
|
|
2015
Q2 | $893K | Hold |
1,275,000
| – | – | 0.12% | 84 |
|
|
2015
Q1 | $864K | Hold |
1,275,000
| – | – | 0.11% | 85 |
|
|
2014
Q4 | $1.01M | Hold |
1,275,000
| – | – | 0.12% | 78 |
|
|
2014
Q3 | $594K | Sell |
1,275,000
-4,000,000
| -76% | -$1.94M | 0.07% | 88 |
|
|
2014
Q2 | $2.64M | Hold |
5,275,000
| – | – | 0.32% | 59 |
|
|
2014
Q1 | $1.64M | Sell |
5,275,000
-25,000
| -0.5% | -$9.29K | 0.2% | 69 |
|
|
2013
Q4 | $1.8M | Buy |
5,300,000
+1,275,000
| +32% | +$1.54M | 0.23% | 60 |
|
|
2013
Q3 | $8.13M | Hold |
4,025,000
| – | – | 1.08% | 32 |
|
|
2013
Q2 | $7.65M | Buy |
+4,025,000
| New | +$7.07M | 1.02% | 32 |
|
Michael F. Price's GCVRZ Position: Q1 2020 in Review
Michael F. Price sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 3,583,668 shares — an estimated $3.08M sold.
Michael F. Price first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $8.13M in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- Michael F. Price reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- Michael F. Price sold 3,583,668 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $3.08M.
- Michael F. Price first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- Michael F. Price's Sanofi Contingent Value Rights position peaked at $8.13M in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on Michael F. Price's 13F filing for Q1 2020, filed 14 May 2020.